Solana (HSDT) vs Nexalin Technology (NXL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Solana is the larger company by market cap ($155.6 million vs $3.0 million), about 51.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSDT | NXL |
|---|---|---|
| Share price | $2.39 | $3.63 |
| Market cap | $155.60M | $3.01M |
| 1-day change | +0.42% | -11.68% |
| YTD return | -17.65% | — |
| 1-year return | -86.80% | — |
| 5-year return | -100.00% | — |
| P/E ratio (TTM) | 0.04 | — |
| EPS (TTM) | $53.74 | $-14.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.81 | $50.70 |
| 52-week low | $1.19 | $3.50 |
| Distance from 52-week high | -85.78% | -92.84% |
| Analyst consensus | none | buy |
| Avg. price target upside | +46.44% | +313.22% |
| Average volume | 351.13K | 1.02M |
| Shares outstanding | 65.10M | 829.40K |
| Employees | 21 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Solana is about 51.7 times larger than Nexalin Technology by market value ($155.60M vs $3.01M).
About Solana
HSDT stock →Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 21 employees
About Nexalin Technology
NXL stock →Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 8 employees
HSDT vs NXL FAQ
Which is bigger, Solana or Nexalin Technology?
Solana (HSDT) is larger, with a market capitalization of $155.60M compared with $3.01M for Nexalin Technology (NXL).
Are Solana and Nexalin Technology in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.